| # | Drug | Count |
|---|---|---|
| 0 | CILTACABTAGENE AUTOLEUCEL | 80 |
| 1 | CYCLOPHOSPHAMIDE | 21 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 4 | DEXAMETHASONE | 21 |
| 5 | DEXAMETHASONE 1.5 MG | 21 |
| 6 | AXICABTAGENE CILOLEUCEL | 19 |
| 7 | FLUDARABINE PHOSPHATE | 18 |
| 8 | TOCILIZUMAB | 15 |
| 9 | ANAKINRA | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OBECABTAGENE AUTOLEUCEL | 9 | 0.1268 |
| 1 | SILTUXIMAB | 8 | 0.0123 |
| 2 | CILTACABTAGENE AUTOLEUCEL | 80 | 0.0122 |
| 3 | IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA | 1 | 0.0040 |
| 4 | BREXUCABTAGENE AUTOLEUCEL | 8 | 0.0037 |
| 5 | LIFILEUCEL | 1 | 0.0035 |
| 6 | IDECABTAGENE VICLEUCEL | 4 | 0.0032 |
| 7 | AXICABTAGENE CILOLEUCEL | 19 | 0.0019 |
| 8 | ISRADIPINE | 1 | 0.0018 |
| 9 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 8 | 0.0123 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 19 | 0.0019 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 4 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |